| Date |
Title |
|
|
May 18, 2020
|
Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19
|
|
|
May 4, 2020
|
Fulgent Genetics Reports First Quarter 2020 Financial Results
|
|
|
April 9, 2020
|
Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020
|
|
|
April 9, 2020
|
Fulgent Genetics Provides Update on Testing for COVID-19
|
|
|
March 17, 2020
|
Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)
|
|
|
March 10, 2020
|
Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
|
|
|
March 10, 2020
|
Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer
|
|
|
February 20, 2020
|
Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020
|
|
